Posted: March 6th, 2013 | Author: pass3191 | Filed under: Passport Health Sarasota-Bradenton Announcements | Tags: Passport Health Reviews, Testimonials | Comments Off on Praise for Passort Health of Sarasota-Bradenton
On November 27, 2013
We were delighted to find out about this business. We needed TDap shots in a hurry because we’re expecting a new grandchild. We thought we could just breeze into the local health dept. and get them. Not so, there was a waiting list for an appt. so they told us about this place. Well, it was great. Straight in, no wait, beautiful office, and our nurse ‘Dee Dee’ was a sweetheart and gave really painless injections. She was very helpful answering questions and giving advice that she thought would benefit us. I would use this service again and highly recommend them.
On November 25, 2013
Great explanations and suggestions were made for my upcoming trips.
On November 23, 2013
Dee Dee Eldridge was extremely helpful in administering the Shots and was outstanding in her overall performance.
My experience with Passport Health was very good. Easy to make an appointment, friendly atmosphere and very efficient. This was not my first experience, I returned because all my questions could be answered quickly and correctly. I thought the printout I was given was very detailed and helpful. Thank you!
On November 15, 2013
Dee Dee was extremely knowledgeable, courteous, and helpful. She was able to answer all of our questions and offer expert advice. She is very professional and sets a high standard for her field of practice.
On November 3, 2013
Very helpful and knowledgeable: 5 out of 5.
On October 14, 2013
My family doctor recommended I check with Passport Health to make certain that I was properly immunized prior to my trip to South Africa and Zimbabwe. The nurse I had during my office visit was Dee Dee and she was EXCELLENT! She gave me all the choices for immunizations, her recommendations, and answered every possible question I had plus gave me valuable information I didn’t even think to ask! All vaccines are available at your office visit, so there is no rescheduling and/or waiting. The PERFECT place to go prior to an out of the country trip. HIGHLY RECOMMEND!
On September 21, 2013
The service we received was outstanding. They made what could be a stressful experience almost relaxing by combining a welcoming environment with efficient service. I would definitely recommend your services to others requiring assistance with a green card medical.
On September 14, 2013
Efficient and thorough. Knowledgeable professional; well prepared and well versed on our options. Good advice.
“Bang up job!”
On August 26th, 2013:
“Fantastic service, friendly atmosphere, “painless shots”, would recommend to anyone.”
On July 10, 2013:
I was greeted warmly and immediately by name. I was on time and they were ready and expecting me. The nurse was very professional, as well as friendly. She had a very clear explanation for my questions and it was obvious to me she knew what she was talking about without being a show off! She helped me understand what I can do to protect my health during my travels. It was a positive experience. It lost the edge of just something else I HAD to do!
Super professional. The service was prompt and kind, all questions were answered vaccination was painless, I am very satisfied.
The RN was very knowledgeable and thorough–I would definitely use your services for future trips.
On July 1, 2013:
Super professional. The service was prompt and kind, all questions were answered vaccination was painless, I am very satisfied. The RN was very knowledgeable and thorough–I would definitely use your services for future trips.
On June 5, 2013:
We had a very bad experience at another clinic (Tampa) with an immigration exam that took extreme advantage of a desperate situation. We called Dee Dee the administrator at Passport Health to verify if what had happened was valid and she went above and beyond to inform us correctly the laws and guidelines and quickly spoke and emailed us proper and professional guidelines that were being corrupted. We had deadlines in just a few short days, and Dee Dee just stepped in to rescue us from a terrible experience and righted the wrongs done to us. Thank you Passport Health for coming to our rescue. Praise the Lord! Very courteous, professional, and informed!!!! Be careful where you go, ask lots of questions, there are a lot of snakes out there…but be confident at Passport Health to be taken care of with dignity and respect!
On May 8, 2013:
Very Professional, Very enlightening, Very Efficient
On March 27, 2013:
I really appreciate the thoroughness, friendliness, and attention to detail. Great experience.
On March 27, 2013:
The nurse I spoke with was well prepared, friendly and very helpful. I waited only a few minutes for the consultation. I am quite satisfied.
On March 27, 2013:
The treatment I received at Passport Health was above and beyond anything I’ve received from any medical professional in quite some time. I got advice not only about the shots I needed for my travel, but years of travel tips, and a good idea for another medical issue I had been dealing with. I highly recommend Passport Health.
On March 26, 2013:
Great Support. The nurse spent a long time with us on the telephone to answer all our questions. Her technique giving the shots was also excellent
On March 5, 2013:
We attended for travel vaccinations and received excellent advice.
From another client, same day:
Lovely, on time and pleasant experience
If you need injections for travel this is the best possible place to get them
Posted: June 4th, 2014 | Author: pass3191 | Filed under: Passport Health Sarasota-Bradenton Announcements | Tags: Brazil, Travel Health, Travel Vaccines, World Cup | Comments Off on Visit Your Travel Clinic Before You Visit Brazil
Reposted from foxnews.com/health
An aerial shot shows the Maracana stadium, one of the stadiums hosting the 2014 World Cup soccer matches, in Rio de Janeiro. (REUTERS/Ricardo Moraes)
Those visiting Brazil should see their doctors or travel medicine specialists four to six weeks before traveling, researchers from the U.S. Centers for Disease Control and Prevention (CDC) in Atlanta write in JAMA Internal Medicine.
“We’re expecting that a lot of Americans will attend and we want to give them a chance to review some of the health and safety issues that come with attending World Cup-like events in a country like Brazil,” said Joanna Gaines, a senior epidemiologist at the CDC and lead author of the statement.
The CDC has already issued a travel advisory for U.S. citizens heading to the World Cup, which takes place in 12 cities throughout Brazil between June 12 and July 13 (see: 1.usa.gov/1mKeX2I).
The 2016 Olympics will be held in Rio de Janeiro from August 5 through August 21 of that year.
Gaines and her colleagues write that mass gatherings such as the World Cup and Olympics have been associated with illness outbreaks before.
For example, six different flu strains were behind an outbreak at the 2008 World Youth Day in Sydney, Australia. Also, there were meningococcal outbreaks following a 1997 soccer tournament in Belgium and the 2000 Hajj pilgrimage in Saudi Arabia.
“We want to make sure that we can get our prevention message out to as many healthcare providers as we can,” Gaines told Reuters Health.
The health agency’s recommendations include receiving routine vaccines for preventable illnesses – such as the flu and measles, mumps and rubella, but also for other diseases, such as typhoid and yellow fever.
Seeing a doctor early “typically gives you enough time for vaccines to gain efficacy,” Gaines said.
While more time is ideal, Dr. Henry W. Murray said even people who may have forgotten to see a travel medicine specialist should make an appointment.
But, he agreed, “The best protection is to get it all done and out of the way a few weeks before departure.”
Murray was not involved with writing the new report. He studies infectious diseases at Weill Cornell Medical College and New York-Presbyterian Hospital in New York City.
There are no vaccines for certain other illnesses, such as malaria and dengue that are spread by mosquitoes. Both are serious and are accompanied by flu-like symptoms.
For malaria, there are pills available to protect against the disease but none is 100-percent effective, according to the CDC’s website. There are no pills that prevent against dengue.
“We recommend that travelers regularly apply insect repellent and wear long sleeve clothing that’s also treated with insect repellant,” Gaines said.
She added that it’s important for people to know that while malaria is spread by mosquitoes that typically bite at night, dengue-carrying mosquitoes generally strike during the day.
The CDC’s report also provides tips on how to prevent food-borne illnesses. Those tips include drinking bottled water, eating steaming-hot foods and washing one’s hands.
“Your basic health protection measures help a lot as far as any infectious diseases are concerned,” Gaines said.
For more information on their recommendations, the researchers write that people can visit wwwnc.cdc.gov/travel.
“People ought to be encouraged to go to the website,” Murray said. “I would have that in my hand before I call my primary care doctor or before I start looking around for a travel care clinic.”
Posted: July 9th, 2013 | Author: pass3191 | Filed under: Passport Health Sarasota-Bradenton Announcements, Travel Health Alerts | Tags: Japanese Encephalitis, South Korea, Travel Health Alerts | Comments Off on Health Alert: JAPANESE ENCEPHALITIS – SOUTH KOREA: (BUSAN) ALERT
JAPANESE ENCEPHALITIS – SOUTH KOREA: (BUSAN) ALERT
ProMED-mail: Published Date: 2013-07-08
Japanese Encephalitis Alert in South Korea
Over half, or 64 per cent, of the mosquitoes recently tested in the southern port city of Busan (Pusan) were found to be carrying the Japanese encephalitis virus (JEV), prompting the Korea Centers for Disease Control and Prevention (KCDC) to issue a nationwide alert late last week (week of 1 Jul 2013).
Officials say climate change is helping the virus-infected mosquitoes breed (probably referring to increased temperatures speeding larval development)
Symptoms of the disease include headaches, fever, and convulsions, and in extreme cases, coma (and death). Children are at higher risk, so officials advise parents to make sure young kids are vaccinated.
As the mosquitoes are most active until the end of October, the KCDC advises people to use mosquito nets indoors and limit the amount of time they spend outside.
When outdoors, the use of long-sleeved clothing and mosquito repellent is recommended.
ProMED-mail from HealthMap Alerts
Posted: January 3rd, 2013 | Author: Passport Health | Filed under: Travel Vaccines Updates | Tags: FDA, Hepatitis, Hepatitis B vaccine, Vaccine | Comments Off on New Hepatitis Vaccine May Soon Be Available
California’s Dynavax Technologies scored a win when FDA staff said the company’s Heplisav vaccine works against the contagious liver disease hepatitis B.
The FDA said in a report that Heplisav worked as well after two doses as three doses of GlaxoSmithKline’s Engerix-B vaccine. The vaccine also had a similar safety profile to Engerix-B.
Company stock rose 13% upon the news, closing Tuesday at $4.74. This marks the largest single-day jump since September 2011.
Dynavax does not yet have a product on the market, so Heplisav will be first should the FDA approve the vaccine Feb. 24, when the organization is scheduled to make a decision. The product could rake in an estimated $775 million in worldwide sales come 2020, Katherine Xu, an analyst with William Blair & Co., told Bloomberg.
In a study of about 2,400 patients ages 18 to 55, 95% of those who took two doses of Heplisav were protected from hepatitis B. By comparison, 81% of those who took three doses of Glaxo’s Engerix-B were protected.
Posted: January 1st, 2013 | Author: Passport Health | Filed under: Travel Vaccines Updates | Tags: Bill & Melinda Gates Foundation, GlaxoSmithKline, Malaria, Vaccine, World Health Organization | Comments Off on Potential New Malaria Vaccine Tests Poorly
A GlaxoSmithKline malaria vaccine posted surprisingly lackluster results in a Phase III trial, putting a damper on solid results from previous studies. The vaccine against the mosquito-borne illness proved only 30% effective when given to African children in a clinical trial.
Still, GSK plans to move forward with development of the vaccine. The trial included 6,537 babies aged 6 to 12 weeks; the vaccine offered “modest protection,” knocking down episodes of the disease 30% compared with the immunization with a control vaccine.
“The efficacy is lower than what we saw last year with the older 5-17 month age category, which surprised some of us scientists at the African trial sites,” Dr. Salim Abdulla, a principal investigator for the trial from the Ifakara Health Institute in Tanzania, said in a release. “It makes us even more eager to gather and analyze more data from the trial to determine what factors might influence efficacy against malaria and to better understand the potential of RTS,S in our battle against this devastating disease.”
In 2010, malaria caused an estimated 655,000 deaths, mostly among African children, the World Health Organization says.
The Phase III trial, completed in conjunction with PATH Malaria Vaccine Initiative, was backed by $200 million from the Bill & Melinda Gates Foundation. Bill Gates, whose organization commits billions of dollars to improving global health, said the study marked an important milestone.
“The efficacy came back lower than we had hoped, but developing a vaccine against a parasite is a very hard thing to do,” Gates said in a statement. “The trial is continuing and we look forward to getting more data to help determine whether and how to deploy this vaccine.”
Posted: December 27th, 2012 | Author: Passport Health | Filed under: Travel Vaccines Updates | Tags: Fluzone, Influenza vaccine, Novartis, OptaFlu, Sanofi Pasteur, Vaccine | Comments Off on Flu Vaccination Rates Disappointing
Every flu season is different. Strains evolve and influenza vaccine manufacturers alter their formulas to meet those changes, covering the three influenza viruses that research indicates will be most prevalent during a given season.
But despite the wide availability of a vaccine–the U.S. FDA green-lighted influenza vaccines from 6 vaccine manufacturers this year–the illness remains a killer. Between 1976 and 2007, estimates of the number of flu-associated deaths range from 3,000 to 49,000, the Centers for Disease Control reports. About 90% of those deaths happened among people ages 65 and older.
Further, vaccination rates last year fell far below the CDC’s target rates of 80%, coming in at around 42%. About 39% of adults were vaccinated during the 2011-2012 influenza season, compared with 75% of children between the ages of 6 months and 23 months and just more than a third of adolescents.
This year, a total of 135 million doses of influenza vaccine will be on hand.
So, what do these less-than-stellar vaccination rates mean for sales? Looking at actual worldwide 2011 sales numbers and estimated worldwide 2012 sales numbers provided by EvaluatePharma, it seems sales as a whole are only slightly up for the top 10 best-selling flu vaccines.
Novartis will likely see the biggest jump in sales of its OptaFlu vaccine; the company reported $36 million in 2011 sales and EvaluatePharma projects $71 million in 2012 sales. Sanofi’s and Sanofi Pasteur MSD’s Fluzone (sold as Vaxigrip outside the U.S.) will likely bring a $10 million jump in sales, from $1.333 billion in 2011 to a projected $1.343 billion this year.
The outlook isn’t all promising for the top 10, though. Abbott Laboratories’ Influvac will probably see a $10 million drop, from $198 million in 2011 sales to an estimated $188 million in 2012. Mitsubishi Tanabe Pharma’s BIKEN HA vaccine will also lose out, slumping by $6 million from $114 million in 2011 sales to a projected $108 million in 2012.
“The changing world demographic provides a definite opportunity for companies offering flu vaccines, as populations age and chronic conditions become more prevalent,” Moser said. “With this trend towards an older, less healthy population, demand should continue to increase for flu vaccines for the foreseeable future, with a non-specific vaccine that can protect against ever-evolving influenza strains being the holy grail in this space.”
Posted: December 25th, 2012 | Author: Passport Health | Filed under: Travel Vaccines Updates | Tags: Methamphetamine, Scripps Research Institute, Vaccine | Comments Off on Merry Christmas and Potential New Vaccine Against Meth Addiction
A team of scientists at the Scripps Research Institute saw promising results in a study of a vaccine against methamphetamine. With more than 430,000 users nationwide, methamphetamine has become one of the most common recreational drugs in the U.S.
The early-stage study, released in the journal Biological Psychiatry, showed that the vaccine protected against meth intoxication in laboratory animals. The compound MH6 blocked two effects of meth in rats given the drug: high energy levels and increased body temperature. This may indicate that the vaccine was preventing methamphetamine from reaching the nervous system.
A healthy antibody response in rats given MH6 also led scientists to believe the body was fighting the drug.
“This is an early-stage study, but its results are comparable to those for other drug vaccines that have gone to clinical trials,” Michael Taffe, a Scripps researcher with the institute’s Committee on the Neurobiology of Addictive Disorders, told California Watch. “It looks promising, but we’re still early on in the process.”
Unfortunately, effects of the vaccine last only weeks, not years. But research is still in its infancy.
Posted: December 20th, 2012 | Author: Passport Health | Filed under: Travel Vaccines Updates | Tags: AIDS Vaccines, Food and Drug Administration, HIV, Schulich School of Medicine & Dentistry, Vaccine | Comments Off on Progress in the Quest for an AIDS Vaccine
Good news out of Canada in the search for an HIV vaccine: Scientists announced a vaccine candidate showed no adverse effects and significantly boosted immunity in human trials.
Researchers from the Schulich School of Medicine & Dentistry at Western University in Ontario are working on a vaccine dubbed SAV001-H, the only HIV vaccine being developed in Canada. The vaccine, approved by the FDA for clinical trials last year, uses a killed whole HIV-1 virus to spark an immune response. The same strategy was used to develop influenza, polio, rabies and hepatitis A vaccines.
In the Phase I study, HIV-positive men and women aged 18 to 50 were split into two groups, with 18 people receiving the vaccine and 6 getting a placebo.
“There were no adverse effects,” Dr. Chil-Yong Kang, professor of virology at the Schulich School of Medicine & Dentistry, told the Toronto Star. “And after the vaccination, the level of (HIV-1) antibodies increased significantly. That means our vaccine is working to stimulate the immune responses.”
In one individual, researchers saw a thirty-twofold increase in the level of HIV-1 antibodies. Another showed a tenfold increase.
Now, researchers will move on to Phase II, a study slated to begin next year. This yearlong study will test the vaccine on 600 HIV-negative volunteers at high risk for infection so researchers can gauge immune response.
Posted: December 18th, 2012 | Author: Passport Health | Filed under: Travel Vaccines Updates | Tags: Bill & Melinda Gates Foundation, Malaria Vaccines, The Global Fund to Fight AIDS Tuberculosis and Malaria, United Nations System, World Health Organization | Comments Off on Controversy Over Pricey Malaria Program
Health officials have clashed over the effectiveness of a pricey malaria program intended to provide cheap drugs for poor patients. In 2010, the Affordable Medicines Facility for malaria was founded by groups including United Nations agencies and the Global Fund to Fight AIDS, Tuberculosis and Malaria, Boston.com reports. The initiative–with a price tag of more than $460 million–was tested in 8 countries. The international charity Oxfam dubbed the program a failure, saying there was no proof it saved lives because officials didn’t track who received drugs and therefore couldn’t conclude whether they reached the right patients. Story
Posted: December 13th, 2012 | Author: Passport Health | Filed under: Travel Vaccines Updates | Tags: Menactra, Menomune, Mumps, Mumps Vaccine | Comments Off on Stay Away from Those Infected by Mumps, Repeated Exposure Could Overwhelm Your Vaccine
A recent study shows close, repeated contact with a person with mumps can overwhelm the mumps vaccine.
The study, published in The New England Journal of Medicine, comes after a face-to-face educational technique used among Orthodox Jews apparently led to an outbreak of mumps in 2009 and 2010, despite widespread vaccination, Reuters reports. In a one-year period beginning June 2009, 3,502 cases were reported in New Jersey, New York City and New York’s Orange and Rockland counties. The study examined 1,648 of those cases–almost all in Orthodox Jews–and found 89% had received two doses of the vaccine and 8% received one dose.
Many of the individuals attended a religious school where they practiced an intense training technique called yeshiva. This technique involves close contact with a partner across a narrow table; partners change frequently.
“The risk of infection with mumps may be higher when the exposure dose of virus is large or intensely transmitted,” the report says (as quoted by Reuters).
This prolonged, face-to-face contact apparently overcame the protection the vaccine provided. The study did find high rates of two-dose coverage reduced the severity of the disease and the transmission to people in settings of less exposure. And because the mumps didn’t spread to other communities, it shows the vaccine, in most cases, is effective.